1. |
- Agnati, LF, et al.
(author)
-
Possible relevance of receptor-receptor interactions between viral- and host-coded receptors for viral-induced disease
- 2007
-
In: TheScientificWorldJournal. - : Hindawi Limited. - 1537-744X. ; 7, s. 1073-1081
-
Journal article (peer-reviewed)abstract
- It has been demonstrated that some viruses, such as the cytomegalovirus, code for G-protein coupled receptors not only to elude the immune system, but also to redirect cellular signaling in the receptor networks of the host cells. In view of the existence of receptor-receptor interactions, the hypothesis is introduced that these viral-coded receptors not only operate as constitutively active monomers, but also can affect other receptor function by interacting with receptors of the host cell. Furthermore, it is suggested that viruses could also insert not single receptors (monomers), but clusters of receptors (receptor mosaics), altering the cell metabolism in a profound way. The prevention of viral receptor-induced changes in host receptor networks may give rise to novel antiviral drugs that counteract viral-induced disease.
|
|
2. |
|
|
3. |
|
|
4. |
- Gennari, R, et al.
(author)
-
Early detection of cancer: ideas for a debate.
- 2007
-
In: critical reviews in Oncology Hematology. - : Elsevier BV. - 1040-8428. ; 61, s. 97-103
-
Journal article (peer-reviewed)abstract
- Even if the overall number of cancer is increasing, the mortality has started to decrease in the Western World. The role of early detection in this decrease is a matter of debate. To assess its impact on mortality it is important to distinguish between diagnosis of cancer in symptomatic patients, and early detection in asymptomatic individuals who may self-refer or who may be offered ad hoc or systematic screening. The policies for early detection and screening vary greatly between European countries, despite many similarities in their cancer burden, and this partly reflects the uncertainties surrounding asymptomatic testing for cancer. A Task Force of European expert, held in Azzate (VA), Italy, established to address these issues, acknowledged the need for more research in the field of individual risk assessment since general statistics are more and more perceived as inadequate to design personal early detection plans. The group also recognised that combinations of early detection and screening will enforce the effectiveness of new treatments in curbing mortality curves, although policies will vary with different cancers.
|
|
5. |
|
|